Trojan Horse Antibiotics–A Novel Way to Circumvent Gram-Negative Bacterial Resistance?

by Glenn S. Tillotson
Published 2016-01-01

Trojan Horse Antibiotics—A Novel Way to Circumvent Gram-Negative Bacterial Resistance?

by Glenn S. Tillotson
Published 2016-10-01

Antibiotic Development and the Evolving Role of Pharmacodynamics — As Good as It Gets?

by Glenn S. Tillotson, Stephen H. Zinner
Published 2015-07-01

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

by Patrick J. Scoble, Joseph Reilly, Glenn S. Tillotson
Published 2020-06-01

Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006

by Marya D. Zilberberg, Glenn S. Tillotson, L. Clifford McDonald
Published 2010-04-01

The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Stud...

by Sandy Estrada, Thomas P. Lodise, Glenn S. Tillotson, Dino Delaportas
Published 2020-06-01